Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R5RW
|
||||
| Former ID |
DNC014183
|
||||
| Drug Name |
4-Nitrophenyl 4-Benzylpiperazine-1-carboxylate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530654] | ||
| Formula |
C18H19N3O4
|
||||
| Canonical SMILES |
C1CN(CCN1CC2=CC=CC=C2)C(=O)OC3=CC=C(C=C3)[N+](=O)[O-]
|
||||
| InChI |
1S/C18H19N3O4/c22-18(25-17-8-6-16(7-9-17)21(23)24)20-12-10-19(11-13-20)14-15-4-2-1-3-5-15/h1-9H,10-14H2
|
||||
| InChIKey |
HNIDATBYDXCKRE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530654] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||